TALOPH(SH:600222) Sou Hu Cai Jing·2025-09-02 02:13Group 1 - The core point of the news is that Tai Long Pharmaceutical (600222) has seen a net financing inflow of 680.54 million yuan on September 1, 2025, with a total financing balance of 3.2 billion yuan, indicating a positive investor sentiment towards the stock [1][2][3] - In the last three trading days, the cumulative net financing inflow reached 1,768.29 million yuan, and in the last 20 trading days, there were 12 days with net financing inflows [1][2] - The financing balance increased by 2.18% compared to the previous day, reflecting a bullish market sentiment [3] Group 2 - On September 1, 2025, the financing balance was 3.20 billion yuan, which accounted for 7.90% of the circulating market value [2] - The financing inflow on August 29 was 176.14 million yuan, and on August 28, it was 911.61 million yuan, indicating consistent investor interest [2] - The financing balance has shown fluctuations, with a decrease of 754.86 million yuan on August 27, highlighting the volatility in investor behavior [2][3]